ID   WAe001-A-53
AC   CVCL_A1MX
SY   H1-ANP32A-/-; NFYYe002-A-53
DR   BioSamples; SAMEA7542501
DR   hPSCreg; WAe001-A-53
DR   Wikidata; Q102115100
RX   PubMed=33607472;
CC   From: Nanfang Hospital, Southern Medical University; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 13233; ANP32A.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
RX   PubMed=33607472; DOI=10.1016/j.scr.2021.102234;
RA   Zhang C., Wei Y.-X., Zhang Y.-Q., Zhang J.-Y., Xing Q., Zhou M.,
RA   Shan Y.-L.;
RT   "Establishment of a CRISPR/Cas9-mediated ANP32A homozygous knockout
RT   human embryonic stem cell line.";
RL   Stem Cell Res. 52:102234-102234(2021).
//